title: [Metabolism pathways and use of heptral in chronic liver diseases].
abstract: Heptral (Ademetionine) plays one of the main functions in the intermediate metabolism, takes part in the processes of methylation and transulfurization and aminopropylation. The use of Heptral in patients with chronic liver diseases with accompanying holystase and encephalopathy of different degree, at depressions, related to alcohol and toxic liver disorders, is pathogenically reasoned for prevention of liver encephalopathy.
authors.affiliation: Central Research Institute of Gastroenterology, Moscow.
authors.forename: L Iu
authors.initials: LIu
authors.lastname: Il'chenko
authors.forename: E V
authors.initials: EV
authors.lastname: Vinnitskaia
mesh_terms: D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006525:Hepatitis, Viral, Human / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008107:Liver Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000821:virology; D012436:S-Adenosylmethionine / Q000627:therapeutic use*
chemical_list: D012436:S-Adenosylmethionine
vernacular_title: Puti metabolizma i primenenie geptrala pri khronicheskikh zabolevaniiakh pecheni.